Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia
Status:
Completed
Trial end date:
2018-03-27
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, active-controlled, multicenter phase 3 trial to evaluate efficacy
and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with
hypertension and hyperlipidemia.